Effectiveness of TCBT in Managing Anxiety Symptoms in Patients with Psychosomatic Disorders

Abstract

Anxiety symptoms are prevalent in psychosomatic disorder patients and can have a significant impact on their quality of life. CBT has shown promise in managing anxiety symptoms in patients with somatoform disorders, but most evidence-based treatments are created and certified for particular conditions, making treatment planning difficult. Transdiagnostic cognitive behavioural therapy (TCBT) is a new approach that seeks to treat common underlying mechanisms in a variety of disorders, including anxiety. Although there is substantial evidence supporting the efficacy of transdiagnostic cognitive-behavioral therapy (TCBT) for children and adolescents, it is not commonly used and is still an emerging field. Additionally, there has been limited research conducted in this domain. To address this gap, the current study examines new illnesses with comparable characteristics to determine which illness responds best to TCBT. The researcher used deliberate sampling to gather data on fifteen individuals with both somatoform disease and anxiety for this study, with both treatment and control groups ongoing 8-12 sessions of TCBT. Before and after therapy, both groups were evaluated using identical scales, and the data were analysed using repeated measures ANOVA. The treatment group experienced a significant reduction in anxiety, demonstrating the effectiveness of transdiagnostic CBT in treating anxiety symptoms. TCBT has been shown in several trials to be successful in reducing anxiety symptoms and improving physical functioning in patients with somatoform disorders and medically unexplained physical symptoms. According to the findings of these studies, TCBT may be a potential therapeutic strategy for patients who also suffer from comorbid anxiety and psychosomatic disorders. To investigate the long-term effects and possible drawbacks of TCBT in this population, more study is required.